BDP
Showing 1 - 25 of 138
Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB
Recruiting
- Asthma
- Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
- +2 more
-
Edegem, Antwerpen, BelgiumSGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023
Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)
Recruiting
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- CHF5993
- +3 more
-
Baltimore, MarylandPAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023
ivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs
Not yet recruiting
- COPD
-
Budapest, HungaryNational Korányi Institute of Pulmonology
Feb 15, 2023
Pulmonary Disease, Chronic Obstructive, Asthma Trial in Gauting (BDP/formoterol NEXT DPI)
Completed
- Pulmonary Disease, Chronic Obstructive
- Asthma
- BDP/formoterol NEXT DPI
-
Gauting, GermanyInamed Research GmbH & Co. KG
Oct 28, 2021
Mild Persistent Asthma Trial in London (BDP/formoterol, Placebo)
Completed
- Mild Persistent Asthma
- BDP/formoterol
- Placebo
-
London, United KingdomRespiratory Clinical Trials - Heart Lung Centre - Queen Anne Str
Oct 28, 2021
Effectiveness, and Safety ofFixed-dose Combination of
Not yet recruiting
- Plaque Psoriasis
- CAL/BDP PAD Cream
- (no location specified)
Mar 31, 2023
Asthmatic Trial in Manchester (NEXThaler 100/6 mcg DPI, Flixotide Accuhaler 500 mcg, NEXThaler 200/6 mcg DPI)
Completed
- Asthmatic
- NEXThaler 100/6 mcg DPI
- +3 more
-
Manchester, United KingdomThe Medicine Evaluation Unit
Oct 28, 2021
Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)
Withdrawn
- Asthma
- MF/F Metered Dose Inhaler (MDI) 25/5 mcg
- +6 more
- (no location specified)
Feb 7, 2022
Real-life: Impact on Adherence and Health Status (TRITRIAL)
Completed
- COPD
- BDP/FF/G fixed combination
-
Rome, ItalyFondazione Policlinico Gemelli
May 4, 2022
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Observational retrospective data collection
- (no location specified)
Dec 14, 2022
Healthy Adult Male Volunteers Trial in Verona (Beclomethasone dipropionate)
Completed
- Healthy Adult Male Volunteers
- Beclomethasone dipropionate
-
Verona, ItalyCentro Ricerche Cliniche AOU Integrata di Verona - Policlinico U
May 3, 2022
Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)
Not yet recruiting
- Asthma
- Beclomethasone Dipropionate/Formoterol Fumarate
- Beclomethasone Dipropionate
- (no location specified)
Mar 14, 2022
COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- BDP/FF/GB
- FlF/VI + Tiotropium
-
Godollo, HungaryErzsebet Gondozohaz
Oct 28, 2021
COPD Trial in Hessen, Szeged, Perugia (BDP/FF/GB, Tiotropium, BDP/FF + Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- BDP/FF/GB
- +2 more
-
Hessen, Germany
- +2 more
Oct 28, 2021
Pulmonary Disease, Chronic Obstructive Trial in Manchester (Glycopyrrolate, Comparator)
Completed
- Pulmonary Disease, Chronic Obstructive
-
Manchester, United KingdomMedicines Evaluation Unit Ltd.
Oct 28, 2021
Pulmonary Disease, Chronic Obstructive Trial in London (CHF1535, Formoterol fumarate)
Completed
- Pulmonary Disease, Chronic Obstructive
- CHF1535
- Formoterol fumarate
-
London, United KingdomUCL Medical School
Oct 28, 2021
Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)
Completed
- Asthma
- CHF1535 200/6 µg
- BDP 100 µg
-
Pisa, ItalyCardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021
BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD
Not yet recruiting
- COPD, Chronic Obstructive Pulmonary Disease
-
Parma, ItalyDepartment of Medicine and Surgery, Respiratory Disease and Lung
Oct 28, 2021
COPD Trial in Szeged (Beclometasone/Formoterol/Glycopyrrolate, Beclometasone/Formoterol)
Completed
- Chronic Obstructive Pulmonary Disease
-
Szeged, HungaryDr Beatrix BALINT
Oct 28, 2021
Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- Therapeutic Dose 1
- +3 more
-
London, Tooting, United KingdomRichmond Pharmacology Ltd
Oct 15, 2021
COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)
Completed
- COPD
- CHF 1535 NEXThaler 800/48
- +4 more
-
Manchester, United KingdomMedicine Evaluation Unit
Oct 28, 2021
Rhinitis, Allergic, Perennial Trial in United States (Beclomethasone dipropionate, Placebo Nasal Aerosol)
Completed
- Rhinitis, Allergic, Perennial
- Beclomethasone dipropionate
- Placebo Nasal Aerosol
-
Oxford, Alabama
- +33 more
Dec 1, 2021
Seasonal Allergic Rhinitis, Hay Fever Trial in United States (Beclomethasone dipropionate, Placebo Nasal Aerosol)
Completed
- Seasonal Allergic Rhinitis
- Hay Fever
- Beclomethasone dipropionate
- Placebo Nasal Aerosol
-
Austin, Texas
- +3 more
Dec 1, 2021
Asthma Trial in Copenhagen (CHF1535 pMDI + AC Plus, BDP + AC Plus, Formoterol + AC Plus)
Completed
- Asthma
- CHF1535 pMDI + AC Plus
- +2 more
-
Copenhagen, DenmarkBorneAstmaKlinikken
Jul 30, 2020